Hepatology International

The growing burden of liver cirrhosis: implications for preventive measures

Martin C. S. Wong, Junjie Huang

Beyond KCH selection and options in acute liver failure

William Bernal, Roger Williams

Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy

Ameer Abutaleb, Shyam Kottilil, Eleanor Wilson

Immune checkpoint receptors: homeostatic regulators of immunity

Antonio Riva, Shilpa Chokshi

Platelets’ increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis

Lin Wang, Bingqiong Wang, Hong You, Xiaoning Wu, Jialing Zhou, Xiaojuan Ou, Jidong Jia

Safety and effectiveness of daclatasvir and asunaprevir dual therapy in patients with genotype 1 chronic hepatitis C: results from postmarketing surveillance in Japan

Fumitaka Suzuki, Naoya Hatanaka, Etsuya Bando, Koji Nakamura, Akira Komoto

Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation

Tetsuyuki Takahashi, Ulrich Deuschle, Shu Taira, Takeshi Nishida, Makoto Fujimoto, Takao Hijikata, Koichi Tsuneyama

Analysis of the high incidence of acute kidney injury associated with acute-on-chronic liver failure

Nan Chen, Xiaohong Chen, Xiaoqiang Ding, Jie Teng

Liver cirrhosis and cancer: comparison of mortality

Wankyo Chung, Changik Jo, Woo Jin Chung, Dong Joon Kim

Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT

Jin-Lin Cheng, Hong Zhao, Shi-Gui Yang, Er-Mei Chen, Wen-Qian Chen, Lan-Juan Li

Correction to: Abstracts of the 27th Annual Conference of APASL, March 14–18, 2018, New Delhi, India

Correction to: Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B

Tianyu He, Yuqing Bai, Haodong Cai, Xiaojuan Ou, Min Liu, Wei Yi, Jidong Jia